These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31769975)

  • 1. Molecular Interaction between Distal C-Terminal Domain of the CB
    Singh P; Ganjiwale A; Howlett AC; Cowsik SM
    J Chem Inf Model; 2019 Dec; 59(12):5294-5303. PubMed ID: 31769975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor.
    Singh P; Ganjiwale A; Howlett AC; Cowsik SM
    J Mol Graph Model; 2017 Oct; 77():311-321. PubMed ID: 28918320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.
    Blume LC; Patten T; Eldeeb K; Leone-Kabler S; Ilyasov AA; Keegan BM; O'Neal JE; Bass CE; Hantgan RR; Lowther WT; Selley DE; Howlett AL
    Mol Pharmacol; 2017 Feb; 91(2):75-86. PubMed ID: 27895162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a.
    Niehaus JL; Liu Y; Wallis KT; Egertová M; Bhartur SG; Mukhopadhyay S; Shi S; He H; Selley DE; Howlett AC; Elphick MR; Lewis DL
    Mol Pharmacol; 2007 Dec; 72(6):1557-66. PubMed ID: 17895407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches.
    Ahmed MH; Kellogg GE; Selley DE; Safo MK; Zhang Y
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1158-65. PubMed ID: 24461351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.
    Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M
    Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
    Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
    Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.
    Blume LC; Eldeeb K; Bass CE; Selley DE; Howlett AC
    Cell Signal; 2015 Mar; 27(3):716-726. PubMed ID: 25446256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1.
    Petgrave M; Ramgoolam SD; Ganesan A
    J Chem Inf Model; 2024 Jan; 64(2):499-517. PubMed ID: 38159053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure.
    Booth WT; Walker NB; Lowther WT; Howlett AC
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31614728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor interacting protein 1a interacts with myristoylated Gα
    Booth WT; Clodfelter JE; Leone-Kabler S; Hughes EK; Eldeeb K; Howlett AC; Lowther WT
    J Biol Chem; 2021 Sep; 297(3):101099. PubMed ID: 34418434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRIP1a inhibits endocytosis of G-protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism.
    Mascia F; Klotz L; Lerch J; Ahmed MH; Zhang Y; Enz R
    J Neurochem; 2017 May; 141(4):577-591. PubMed ID: 28295323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of BiP as a CB
    Costas-Insua C; Moreno E; Maroto IB; Ruiz-Calvo A; Bajo-Grañeras R; Martín-Gutiérrez D; Diez-Alarcia R; Vilaró MT; Cortés R; García-Font N; Martín R; Espina M; Botta J; Ginés S; McCormick PJ; Sánchez-Prieto J; Galve-Roperh I; Mengod G; Urigüen L; Marsicano G; Bellocchio L; Canela EI; Casadó V; Rodríguez-Crespo I; Guzmán M
    J Neurosci; 2021 Sep; 41(38):7924-7941. PubMed ID: 34353897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
    Janero DR; Korde A; Makriyannis A
    Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.
    Janero DR; Yaddanapudi S; Zvonok N; Subramanian KV; Shukla VG; Stahl E; Zhou L; Hurst D; Wager-Miller J; Bohn LM; Reggio PH; Mackie K; Makriyannis A
    ACS Chem Neurosci; 2015 Aug; 6(8):1400-10. PubMed ID: 25978068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.
    Oliver EE; Hughes EK; Puckett MK; Chen R; Lowther WT; Howlett AC
    Biomolecules; 2020 Nov; 10(12):. PubMed ID: 33261012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGIP1 binding to the α-helical H9 domain of cannabinoid receptor 1 promotes axonal surface expression.
    Fletcher-Jones A; Spackman E; Craig TJ; Nakamura Y; Wilkinson KA; Henley JM
    J Cell Sci; 2024 Jun; 137(11):. PubMed ID: 38864427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Expression of CB
    Kozakiewicz ML; Zhang J; Leone-Kabler S; Yamaleyeva LM; McDonald AG; Brost BC; Howlett AC
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):279-288. PubMed ID: 33998898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.